We are live on ! Find out more
GWM

Geneos Wealth Management Portfolio holdings

AUM $4.31B
1-Year Est. Return 18.36%
This Fund
S&P 500
This Quarter Est. Return
-0.12%
1 Year Est. Return
+18.36%
3 Year Est. Return
+53.76%
5 Year Est. Return
+60.8%
10 Year Est. Return
+204.74%
AUM
$4.31B
AUM Growth
+$222M
Cap. Flow
+$277M
Cap. Flow %
6.44%
Top 10 Hldgs %
18.96%
Holding
2,575
New
116
Increased
713
Reduced
638
Closed
110

Sector Composition

Rank Sector Weight
1 Technology 6.31%
2 Financials 3.89%
3 Industrials 3.72%
4 Healthcare 2.96%
5 Energy 2.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VTIP icon
1676
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
$19.1B
$25.9K ﹤0.01%
519
+200
+63% +$9.95K
DJD icon
1677
Invesco Dow Jones Industrial Average Dividend ETF
DJD
$481M
$25.9K ﹤0.01%
434
+1
+0.2% +$60
JIG icon
1678
JPMorgan International Growth ETF
JIG
$467M
$25.9K ﹤0.01%
349
+65
+23% +$5.02K
FNDE icon
1679
Schwab Fundamental Emerging Markets Large Company Index ETF
FNDE
$9.56B
$25.7K ﹤0.01%
673
FITE
1680
State Street SPDR S&P Kensho Future Security ETF
FITE
$144M
$25.7K ﹤0.01%
300
IAK icon
1681
iShares US Insurance ETF
IAK
$514M
$25.7K ﹤0.01%
200
PRGS icon
1682
Progress Software
PRGS
$1.63B
$25.6K ﹤0.01%
+1,000
New +$38.2K
CACI icon
1683
CACI
CACI
$10.9B
$25.6K ﹤0.01%
47
STLA icon
1684
Stellantis
STLA
$16.4B
$25.6K ﹤0.01%
3,605
+1,000
+38% +$8.38K
ASHR icon
1685
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.57B
$25.5K ﹤0.01%
780
UDIV icon
1686
Franklin US Core Dividend Tilt Index ETF
UDIV
$136M
$25.3K ﹤0.01%
491
-2
-0.4% -$107
ATR icon
1687
AptarGroup
ATR
$8.48B
$25.3K ﹤0.01%
201
+137
+214% +$17.9K
SIMS icon
1688
State Street SPDR S&P Kensho Intelligent Structures ETF
SIMS
$8.3M
$25.2K ﹤0.01%
600
STAG icon
1689
STAG Industrial
STAG
$7.8B
$25.2K ﹤0.01%
700
-150
-18% -$5.69K
RACE icon
1690
Ferrari
RACE
$66.5B
$25K ﹤0.01%
74
EQRR icon
1691
ProShares Equities for Rising Rates ETF
EQRR
$32.5M
$25K ﹤0.01%
+360
New +$24.4K
CAPL icon
1692
CrossAmerica Partners
CAPL
$833M
$24.9K ﹤0.01%
1,200
RZV icon
1693
Invesco S&P SmallCap 600 Pure Value ETF
RZV
$292M
$24.9K ﹤0.01%
200
IMVT icon
1694
Immunovant
IMVT
$8.28B
$24.8K ﹤0.01%
1,000
CANE icon
1695
Teucrium Sugar Fund
CANE
$74.5M
$24.8K ﹤0.01%
+2,375
New +$22.8K
IAGG icon
1696
iShares Core International Aggregate Bond Fund
IAGG
$10.9B
$24.8K ﹤0.01%
495
SCHJ icon
1697
Schwab 1-5 Year Corporate Bond ETF
SCHJ
$848M
$24.7K ﹤0.01%
1,000
PEXL icon
1698
Pacer US Export Leaders ETF
PEXL
$50.7M
$24.6K ﹤0.01%
419
SBGI icon
1699
Sinclair Inc
SBGI
$1B
$24.5K ﹤0.01%
1,897
+286
+18% +$4.15K
MPT
1700
Medical Properties Trust
MPT
$2.91B
$24.5K ﹤0.01%
5,300

Similar funds

Geneos Wealth Management's Q1 2026 Portfolio in Review

As of Q1 2026, Geneos Wealth Management held 2,575 positions worth $4.31B, up 5.4% from $4.09B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Geneos Wealth Management deployed $277M of net new capital in Q1 2026, opening 116 new positions and adding to 713 existing holdings. Its largest new stake was iShares Systematic Bond ETF: 84,595 shares worth $7.53M.

By sector, the portfolio is most concentrated in Technology at 6.3% of assets, down from 7.6% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Capital Group Growth ETF, an estimated $27.9M trimmed.

  • Geneos Wealth Management's largest Q1 2026 buy was iShares Systematic Bond ETF: 84,595 shares worth $7.53M.
  • Geneos Wealth Management added most to iShares Core S&P Total US Stock Market ETF in Q1 2026, an estimated $54.8M increase.
  • Geneos Wealth Management's biggest Q1 2026 reduction was Capital Group Growth ETF, cutting an estimated $27.9M.
  • Geneos Wealth Management fully exited AstraZeneca in Q1 2026, selling an estimated $7.53M.
  • Geneos Wealth Management's ten largest holdings make up 19% of its $4.31B portfolio in Q1 2026.
  • Geneos Wealth Management opened 116 new positions and closed 110 in Q1 2026.
  • Geneos Wealth Management's portfolio value rose 5.4% quarter-over-quarter to $4.31B.

Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.